Immediate Impact
3 from Science/Nature 52 standout
Citing Papers
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
2024 Standout
Works of Yuji Baba being referenced
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yuji Baba | 456 | 332 | 687 | 340 | 88 | 1.8k | |
| Sang‐Hue Yen | 348 | 303 | 262 | 501 | 50 | 1.7k | |
| Weining Zhen | 863 | 906 | 471 | 547 | 66 | 2.6k | |
| Quanshi Wang | 247 | 402 | 666 | 291 | 73 | 1.6k | |
| Yee‐Min Jen | 557 | 521 | 237 | 362 | 69 | 1.9k | |
| Masaji Takahashi | 535 | 846 | 510 | 515 | 86 | 2.3k | |
| Jeffrey Meyer | 552 | 755 | 541 | 600 | 122 | 2.3k | |
| Cordula Petersen | 604 | 949 | 634 | 982 | 115 | 2.7k | |
| Eddie Lau | 416 | 609 | 644 | 518 | 75 | 1.8k | |
| Yi Wei | 360 | 312 | 580 | 463 | 110 | 1.6k | |
| Pramod Kumar Julka | 397 | 454 | 327 | 310 | 121 | 1.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...